Zentek (ZTEK) Total Non-Current Liabilities (2021 - 2026)
Zentek (ZTEK) posted Total Non-Current Liabilities of $1.3 million for Q1 2026, up 4.05% sequentially from $1.2 million in Q4 2025, and up 1032.98% YoY from $112717.2 in Q1 2025.
Zentek (ZTEK) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
Zentek has reported Total Non-Current Liabilities for 6 years, with the latest figure at $1.3 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 1032.98% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 1032.98% YoY) and the FY2026 annual result came in at $1.3 million, up 989.22% from the prior year.
- Total Non-Current Liabilities climbed to $1.3 million in Q1 2026 per ZTEK's latest filing, from $1.2 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $1.3 million in Q1 2026 and troughed at $112717.2 in Q1 2025.
- A 5-year average of $609679.2 and a median of $500357.5 in 2023 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities slumped 74.38% in 2025, then surged 1032.98% in 2026.
- Over 5 years, Total Non-Current Liabilities stood at $186696.7 in 2022, then soared by 198.87% to $557978.9 in 2023, then slumped by 73.45% to $148127.8 in 2024, then jumped by 728.56% to $1.2 million in 2025, then gained by 4.05% to $1.3 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.3 million, $1.2 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Zentek | 63.90 Mn | 51.90 Mn | - | 1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 112,717.18 |
| Dec 31, 2024 | 148,127.80 |
| Sep 30, 2024 | 183,725.91 |
| Jun 30, 2024 | 309,562.71 |
| Mar 31, 2024 | 439,955.14 |
| Dec 31, 2023 | 557,978.90 |
| Sep 30, 2023 | 500,357.48 |
| Jun 30, 2023 | 621,526.99 |
| Mar 31, 2023 | 358,646.22 |
| Dec 31, 2022 | 186,696.73 |
| Sep 30, 2022 | 422,293.16 |
| Jun 30, 2022 | 661,430.55 |
| Mar 31, 2022 | 892,600.63 |
| Dec 31, 2021 | 137,097.99 |
| Mar 31, 2021 | 222,707.61 |